Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

INO

Inovio Pharmaceuticals Inc

Jun 14 • 04:00PM ET

9.09

Dollar change -0.36
Percentage change -3.81	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF VHT AVSC DFAC DFUS GERM DFAS QQQS DFAU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.53	Insider Own	0.84%	Shs Outstand	25.91M	Perf Week	-5.21%
Market Cap	235.52M	Forward P/E	-	EPS next Y	-3.19	Insider Trans	0.00%	Shs Float	25.69M	Perf Month	-30.45%
Income	-124.94M	PEG	-	EPS next Q	-1.10	Inst Own	17.04%	Short Float	7.28%	Perf Quarter	-15.32%
Sales	0.72M	P/S	327.11	EPS this Y	27.34%	Inst Trans	46.74%	Short Ratio	5.44	Perf Half Y	100.45%
Book/sh	4.04	P/B	2.25	EPS next Y	27.98%	ROA	-63.15%	Short Interest	1.87M	Perf Year	51.93%
Cash/sh	4.08	P/C	2.23	EPS next 5Y	41.50%	ROE	-85.09%	52W Range	3.89 - 14.75	Perf YTD	48.53%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.49%	ROI	-118.19%	52W High	-38.36%	Beta	0.92
Dividend TTM	-	Quick Ratio	4.77	Sales past 5Y	60.80%	Gross Margin	-333.87%	52W Low	133.80%	ATR (14)	0.63
Dividend Ex-Date	-	Current Ratio	4.77	EPS Y/Y TTM	53.05%	Oper. Margin	-16868.62%	RSI (14)	33.52	Volatility	5.18% 5.69%
Employees	122	Debt/Eq	0.14	Sales Y/Y TTM	-92.95%	Profit Margin	-17423.44%	Recom	2.00	Target Price	18.92
Option/Short	Yes / Yes	LT Debt/Eq	0.12	EPS Q/Q	30.69%	Payout	-	Rel Volume	0.67	Prev Close	9.45
Sales Surprise	-100.00%	EPS Surprise	-29.28%	Sales Q/Q	-100.00%	Earnings	May 13 AMC	Avg Volume	343.66K	Price	9.09
SMA20	-12.92%	SMA50	-16.29%	SMA200	18.51%	Trades		Volume	230,103	Change	-3.81%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-24	Initiated	Stephens	Overweight	$20
Jan-25-24	Upgrade	Oppenheimer	Perform → Outperform	$4
Nov-09-22	Downgrade	Maxim Group	Buy → Hold
Nov-01-22	Downgrade	BofA Securities	Neutral → Underperform	$2
Jul-19-22	Resumed	RBC Capital Mkts	Sector Perform	$5 → $4
May-11-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral	$8 → $10
Dec-29-21	Resumed	Jefferies	Hold	$8 → $6
Sep-10-21	Downgrade	BofA Securities	Neutral → Underperform	$9 → $8
Jun-24-21	Initiated	Jefferies	Hold	$9
Mar-23-21	Initiated	BofA Securities	Neutral	$13
Feb-12-21	Initiated	Oppenheimer	Outperform	$35
Nov-17-20	Downgrade	ROTH Capital	Neutral → Sell
Nov-10-20	Upgrade	ROTH Capital	Sell → Neutral	$8
Sep-28-20	Upgrade	Maxim Group	Hold → Buy	$20
Sep-28-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-01-20	Downgrade	ROTH Capital	Neutral → Sell	$11
Jul-01-20	Downgrade	Maxim Group	Buy → Hold
Jun-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-26-20	Downgrade	Stifel	Buy → Hold	$19 → $24

Show Previous Ratings

Jun-04-24 08:00AM	INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. (PR Newswire)
May-31-24 04:48PM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
May-22-24 09:45AM	Better Buy: Inovio Pharmaceuticals vs. Novavax (Motley Fool)
May-14-24 08:21AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:55AM	Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target (MT Newswires)
03:02AM	Loading…
03:02AM	Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 09:45PM	Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript (Motley Fool) +6.67%
08:55PM	INO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
04:28PM	Inovio: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights (PR Newswire)
May-05-24 08:54AM	This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy? (Motley Fool)
May-01-24 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Apr-29-24 08:00AM	INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 (PR Newswire) +8.80%
08:00AM	INOVIO to Participate in Upcoming Investor Conferences in May (PR Newswire)
Apr-15-24 06:39PM	INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants (PR Newswire)
06:28PM	Loading…
Mar-26-24 06:28PM	INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine (PR Newswire)
Mar-08-24 09:55AM	Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect? (Zacks) +12.74%
Mar-07-24 10:38AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.51%
06:39AM	Q4 2023 Inovio Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-24 11:30PM	Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript (Motley Fool)
09:54PM	INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights (PR Newswire)
07:00AM	Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
Feb-21-24 09:55AM	Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know (Zacks)
08:00AM	INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 (PR Newswire)
Feb-12-24 06:25AM	Inovio (INO) Moves 17.4% Higher: Will This Strength Last? (Zacks) +5.64%
Feb-07-24 11:46AM	INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire)
Feb-02-24 08:00AM	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire) -5.08%
Jan-30-24 09:55AM	How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72% (Zacks) -6.25%
Jan-24-24 09:13AM	Why Is Inovio Pharmaceuticals (INO) Stock Down Today? (InvestorPlace)
08:00AM	Loading…
Jan-23-24 08:00AM	INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split (PR Newswire) -16.15%
Jan-22-24 08:00AM	INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader (PR Newswire)
Jan-12-24 09:43AM	Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why (Zacks) -12.99%
Jan-04-24 08:00AM	INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI (toripalimab-tpzi) (PR Newswire) +9.97%
Jan-03-24 08:00AM	INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program (PR Newswire) -7.70%
Nov-14-23 10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace) +7.14%
Nov-10-23 03:38PM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:00AM	Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-09-23 04:42PM	Inovio: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
Nov-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Oct-26-23 08:00AM	INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 (PR Newswire)
Oct-19-23 09:53AM	Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why (Zacks)
Oct-10-23 08:00AM	INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program (PR Newswire) +41.00%
Sep-28-23 11:10AM	Inovio spinoff Geneos raises another $5M to advance therapeutic cancer vaccines (American City Business Journals)
Sep-27-23 07:39PM	Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million (PR Newswire)
Sep-07-23 08:00AM	INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-06-23 09:31PM	Philadelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022 (American City Business Journals) -5.52%
Aug-29-23 08:00AM	INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire) +8.35%
Aug-09-23 08:30PM	Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript (Motley Fool)
05:40PM	Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Inovio: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update (PR Newswire)
Aug-04-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Jul-26-23 09:32AM	INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023 (PR Newswire)
Jun-23-23 04:10PM	INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions (GlobeNewswire)
Jun-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
May-25-23 08:00AM	INOVIO to Present at the 2023 Jefferies Healthcare Conference (PR Newswire)
May-23-23 04:13PM	INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
May-15-23 12:00PM	All You Need to Know About Inovio (INO) Rating Upgrade to Buy (Zacks) +5.14%
06:08AM	These Analysts Think Inovio Pharmaceuticals, Inc.'s (NASDAQ:INO) Sales Are Under Threat (Simply Wall St.)
May-13-23 08:20AM	Analysts Have Lowered Expectations For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) After Its Latest Results (Simply Wall St.)
May-12-23 06:14AM	Inovio Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) -6.89%
May-11-23 03:30AM	Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript (Motley Fool)
May-10-23 05:45PM	Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
May-08-23 08:00AM	New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023 (PR Newswire)
May-05-23 08:00AM	INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference (PR Newswire)
Apr-28-23 08:00AM	INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 (PR Newswire)
Apr-27-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis at COSM 2023 (PR Newswire)
Apr-26-23 08:00AM	European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107 (PR Newswire)
Apr-17-23 01:55PM	These 3 Nasdaq Stocks Are on Fire Today: Here's Why (Motley Fool) +9.83%
08:00AM	Data from Phase 1b trial with INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) presented at ECCMID 2023 (PR Newswire)
Apr-13-23 02:07PM	Why Inovio Pharmaceuticals' Shares Jumped on Thursday (Motley Fool) +27.53%
Apr-12-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID 2023 (PR Newswire)
Apr-04-23 03:10PM	Why Shares of Inovio Pharmaceuticals Were Down Tuesday (Motley Fool) -8.22%
Apr-03-23 08:00AM	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
Mar-06-23 01:07AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.33%
Mar-03-23 08:00AM	INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference (PR Newswire)
Mar-01-23 07:00PM	Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript (Motley Fool)
06:15PM	Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights (PR Newswire)
Feb-16-23 08:00AM	INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Feb-15-23 08:00AM	INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023 (PR Newswire)
Feb-03-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire) +6.70%
Feb-02-23 01:39PM	Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola (Benzinga) +7.19%
08:00AM	INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) (PR Newswire)
Feb-01-23 01:55PM	3 Sorry Pharma Stocks to Sell in February Before Its Too Late (InvestorPlace)
Jan-31-23 11:40AM	Inovio Pharmaceuticals enacts its second round of layoffs in just over six months (American City Business Journals)
11:07AM	INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates (Benzinga)
08:00AM	INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates (PR Newswire)
Jan-03-23 07:27AM	Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69% (Simply Wall St.)
Nov-18-22 11:42AM	Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs (Benzinga) -8.97%
11:02AM	Inovio shares fall on discontinuation of development of two more vaccine candidates (American City Business Journals)
Nov-17-22 04:30PM	INOVIO Provides an Update on Lassa Fever and MERS Programs (PR Newswire)
09:23AM	3 Stocks to Avoid Right Now (Motley Fool)
Nov-08-22 10:00PM	Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript (Motley Fool)
06:25PM	Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:57PM	What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours (Benzinga)
04:05PM	INOVIO Reports Financial Results and Highlights for the Third Quarter 2022 (PR Newswire)

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INO

Inovio Pharmaceuticals Inc

Upgrade your FINVIZ experience